# Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-romosozumab-versus-teriparatide-for-severe-postmenopausal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hiroshi Hagino,Katsuhiro Tanaka,Stuart L. Silverman,Michael R. McClung,SR Gandra,M. Charokopou,Kazuhide Adachi,Ben Johnson,Björn Stollenwerk |
| Citations | 17 |
| DOI | 10.1007/s00198-021-05927-1 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3136998622 |
| PMID | 33772328 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Ben Johnson](https://scholariq.org/researchers/ben-johnson/)

## Paper primary topic

- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)

## Paper topics

- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)
- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)
- [Bone Metabolism and Diseases](https://scholariq.org/topics/bone-metabolism-and-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.